Speclipse

Developer of an in-vivo imaging technology designed to revolutionize skin cancer diagnosis. The company's platform is based on proprietary technology that offers cellular-resolution imaging of the skin similar to histology without the need for tissue excision and processing, helping healthcare professionals in immediate and non-invasive diagnosis of skin cancers and helping dermatologists to have a deep look at the skin.

Developer of clinical data tools designed for lifesaving diagnosis and therapies for skin diseases. The company's tool deploys computer vision and artificial intelligence technology with image recognition and artificial intelligence-driven recommendations for the diagnosis of pathologies and offers affordable health assistance to achieve efficient clinical decisions, enabling dermatologists to improve diagnosis, score severity, monitor the evolution of wounds, chronic and malignant skin lesions.

Developer of an artificial intelligence-based healthcare technology designed to assist clinicians in detecting and diagnosing cancer. The company's technology develops imaging and multi-omics biomarkers and reporting tools using artificial intelligence and MRI, to support cancer screening and diagnosis, enabling clinicians and physicians to make cancer detection accurate, accessible, cost-effective, and quick.